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A B S T R A C T
Purpose: Previous studies have examined risks of leukaemia and selected lymphoid malignancies in workers
exposed to extremely low frequency magnetic fields (ELF-MF). Most studies evaluated hematolymphopoietic
malignancies as a combined category, but some analyses suggested that effects may be contained to some
specific leukaemia or lymphoma subtypes, with inconsistent results.
Methods: We examined exposure to ELF-MF and mortality 1990–2008 from different types of hematolympho-
poietic cancers in the Swiss National Cohort, using a job exposure matrix for occupations recorded at censuses
1990 and 2000. We analysed 3.1 million workers exposed at different levels to ELF-MF: ever-high, only-medium,
only-low exposure using Cox proportional hazard models. We evaluated risk of death from acute myeloid leu-
kaemia (AML), chronic myeloid leukaemia, lymphoid leukaemia, diffuse large B-cell lymphomas, follicular
lymphoma, Waldenström's macroglobulinemia, multiple myeloma and Hodgkin lymphoma.
Results: Mortality from hematolymphopoietic cancers was not associated with exposure to ELF-MF with the
exception of an increase in ever-high exposed men of myeloid leukaemias (HR 1.31, 95% CI 1.02–1.67), and
AML (HR 1.26, 95%CI 0.93–1.70). If workers had been high exposed during their vocational training and at both
censuses, these HR increased to 2.24 (95%CI 0.91–5.53) and 2.75 (95%CI 1.11–6.83), respectively.
Conclusions: Our analysis provided no convincing evidence for an increased risk of death from a range of he-
matolymphopoietic cancers in workers exposed to high or medium levels of ELF magnetic fields. However, we
observed an increased risk of acute myeloid leukaemia in workers exposed to high levels for a longer duration.
Observed risks are in line with meta-analysed previous reports on ELF-MF exposure and AML risk, with a
summary relative risk of 1.21 (95%CI 1.08–1.37).
1. Introduction
In 2001, the International Agency for Research on Cancer classified
extremely-low frequency magnetic fields (ELF-MF) as “possibly carci-
nogenic”, based on the observation of increased risks of leukaemia in
children exposed to these fields. For adults, ELF-MF exposures at work
can be represent the major determinant of personal exposure. van
Tongeren et al. (2004) Epidemiological studies addressing occupational
ELF-MF exposure and risk of leukaemia in adults have yielded slightly
increased risks in exposed workers: a meta-analysis from 2008 (Kheifets
et al., 2008) reported summary relative risks (sRR) of 1.16 (95%CI
1.11–1.22) for leukaemia, based on 56 study reports. Several studies
have suggested that stronger effects may be observed for some of the
disease subtypes. Feychting et al. (1997); Floderus et al. (1999);
Sorahan (2014) For myeloid neoplasms, the mentioned meta-analysis
(Kheifets et al., 2008) reported sRRs for acute myeloid leukaemia
(AML) of 1.23 (95%CI 1.08–1.41) and for chronic myeloid leukaemia
(CML) of 1.22 (95%CI 0.98–1.52). For acute lymphocytic leukaemia
(ALL), the sRR was 1.37 (95%CI 1.11–1.69) and for chronic lympho-
cytic leukaemia (CLL) 1.35 (95%CI 1.10–1.65). In general, however, no
clear exposure-response pattern emerged from the studies that eval-
uated exposure levels included in this meta-analysis (Kheifets et al.,
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2. Methods
Described in detail elsewhere (Bopp et al., 2009; Spoerri et al.,
2010), the SNC is a longitudinal study based on national censuses. First,
censuses 1990 and 2000 were linked using deterministic and prob-
abilistic record linkage methods. Key variables were sex, date of birth,
place of residence, marital status, religion, nationality and date of birth.
In a second step the census data were linked to the mortality and
emigration registries. Coverage of the census 2000 was virtually com-
plete with 98.6% (Renaud, 2004), and 94% of all deaths between 1991
and 2008 could be linked to a census record.
Linkage of records is less complete in younger persons and we
therefore excluded persons younger than 30 years at time of entry of the
1990 census. The cantonal ethics committees of Bern and Zurich ap-
proved of the study. More information can be found under www.
swissnationalcohort.ch.
2.1. Exposure and outcome information
We analysed causes of death from different malignant neoplasms of
the lymphoid and haematopoietic tissue, recorded anywhere on the
death certificate. We used codes of the International Classification of
Diseases and Related Health Problems, versions 8 and 10 (ICD8/10) for
this purpose, a list of all ICD8 and 10 codes is given in Table 1. ICD8
was used in Switzerland until 1994 and ICD10 was introduced in 1995.
As a negative control outcome, we also evaluated lung cancer (ICD10
code C34 and ICD8 code 162).
The Swiss censuses included information about occupation (i.e. job
title at the time point of the census) and highest qualification obtained.
About 18,000 individual occupations were listed which were translated
into the International Standard Classification of Occupations from 1988
(ISCO88) by the Federal Statistical Office. In contrast to an earlier
publication (Huss et al., 2015), we excluded occupational codes that
provided only as major group codes (e.g. ISCO88 code 3000). We as-
signed intensity of the magnetic field exposure (low, medium, high) to
ISCO88 occupational codes and vocational training (or highest quali-
fication obtained) using a modified version of a previously published
job exposure matrix (Bowman et al., 2007; Huss et al., 2013; Koeman
et al., 2013). In this JEM, the median intensity of the exposures cor-
responded to approximately 0.11, 0.19 and 0.52 µT for low, medium
and high exposure, respectively (Koeman et al., 2013). High exposed
occupations are usually those where workers are placed in close
proximity to machines that use a lot of energy, examples include train
drivers, pilots, welders or machine operators (see also list of ISCO88
unit groups of “high” exposed occupations in eTable 1). All home-
makers as well as people without an occupation at the time of the
census were assigned low exposure. The censuses also provide in-
formation on the highest vocational training a person received, which is
also coded according to ISCO88.
2.2. Statistical analysis
We used Cox proportional hazard models to evaluate the association
between exposure to ELF-MF and mortality from hematolymphopoietic
cancers. We used age as the underlying time scale and adjusted analyses
for sex, nationality, educational level, language region and civil status.
For the main analysis, participants entered the risk set on 4 December
1990, the day of the 1990 census. The observation time ended on 31st
December 2008, the date of emigration or death, whichever came first.
We also evaluated the two censuses separately to assess if observed
patterns were consistent over time: In the analysis of census 1990,
participants entered the risk set on 4 Dec 1990, but the observation
time ended at the latest on 3 December 2000. For the analysis of census
2000, persons entered the risk set on 4 December 2000 and observation
time ended on 31 December 2008. Two outcomes, diffuse large B-cell
lymphoma and Waldenström's macroglobulinemia were only in-
troduced in ICD10. For these outcomes participants entered the risk set
on 1 January 1995, the date of the introduction of ICD10 in
Switzerland. Women work less often in occupations with high exposure
levels than men and may perform different tasks within a certain oc-
cupation, which is why several previous publications reported risk es-
timates restricted to men (Sorahan, 2014; Koeman et al., 2014;
Schroeder and Savitz, 1997; Band et al., 2004). We therefore stratified
the main analyses by sex.
ELF-MF exposure was analysed in three categories, as ever-high,
Table 1
ICD 8 and ICD 10 codes.
ICD8 ICD10
Any hematolymphopoietic cancer 200–209 C81-C96
All types of leukaemias (except lymphoid,
new definition)
205–207 C92-C95
All types of leukaemias (including
lymphoid, old definition)
204–207 C91-C95
Myeloid leukaemias 205 C92
AML 205.0 C92.0
CML 205.1 C92.1
Lymphomas
Non-Hodgkin Lymphomas 200, 202,
204
C82-C85+C88+C91
Lymphoid leukaemias 204 C91
ALL 204.0 C91.0
CLL 204.1 C91.1
B-cell lymphomas
Follicular Lymphoma 202.0 C82
Diffuse large B-cell lymphoma – C83.3
Waldenström's macroglobulinemia – C83.0+C88.0
Multiple myeloma 203 C90
Hodgkin lymphoma 201 C81
Lung cancer 162 C34
Analysed causes of death as registered anywhere on the death certificate. Codes are given
as International Classification of Diseases and Related Health Problems, versions 8 or 10
(ICD8/10).
2008).
Since the meta-analysis from 2008 (Kheifets et al., 2008), several 
publications appeared, but they reported inconsistent results. A large 
study in electric utility workers from England found an increased risk 
for ALL but not for CLL, AML or CML (Sorahan, 2014). In contrast, a 
study of the Dutch general population observed an increased risk for 
AML, but not for ALL, CLL and CML (Koeman et al., 2014). No evidence 
of an increased risk emerged from a very large study performed in the 
Nordic Occupational Cancer Cohort evaluating risk of AML (Talibov 
et al., 2015). Regarding other lymphoid malignancies in exposed 
workers, the results were also inconsistent: the risk of follicular lym-
phoma in ever-high exposed workers was increased in the Dutch study 
(Koeman et al., 2014), and an Australian case-control study found a 
slightly increased risk of non-Hodgkin lymphoma cases (Karipidis et al., 
2007). Electrical workers who had worked for 20 years or longer had a 
slightly increased risk of non-Hodgkin lymphoma compared to persons 
with shorter duration of exposure in a large US-American cohort of 
utility workers, but risks were not elevated for Hodgkin's disease or 
multiple myeloma (Schroeder and Savitz, 1997). Increased risks of non-
Hodgkin lymphoma also emerged from a Canadian case-control study 
in workers of electrical industries (Band et al., 2004).
We used a job exposure matrix approach to evaluate the possible 
association between occupational exposure to ELF-MF and mortality 
from different types of hematolymphopoietic cancers in the Swiss 
National Cohort (SNC), a longitudinal study of mortality of the entire 
population of Switzerland. We also performed a meta-analysis to ex-
amine the association of occupational exposure to ELF-MF with AML 
and to evaluate in how far heterogeneity of results could be explained 
with exposure-assessment related characteristics of the individual stu-
dies.
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only-medium or only-low, stratifying analyses to account for differences
in baseline risk over time (“strata” command in Stata). In the main
analysis, we used the earliest recorded exposure. If the number of ever-
high exposed cases was less than five, we collapsed the ever-high and
only-medium exposure categories into a combined “exposed” category.
If the number of exposed cases was below five, no risk estimates were
calculated. For persons who could be assigned an exposure at both
censuses, we further classified exposure across censuses. Due to low
numbers, we combined workers exposed at only-medium or ever-high
levels into two exposure categories of “ever medium or high” in either
1990 or in 2000, or “always medium or high” (exposed in both cen-
suses) and compared these to workers exposed “always low” (not ex-
posed in either census).
Educational level was classified as low (compulsory schooling or
less), medium (vocational training) or high (tertiary education). The
censuses combined retirees and disabled persons in a single group.
Because the outcomes of interest may be a reason to receive a disability
pension we excluded pensioners from analyses. We restricted our ana-
lysis to economically active people (aged up to 65 for men and up to 62
for women), and in a sensitivity analyses we set all homemakers and
persons seeking a job to low exposure. We explored potential con-
founding by other chemical exposures at work, in particular solvents,
pesticides and herbicides, metals (Koeman et al., 2014; Matheson et al.,
2005), and risk of electrical shocks at work (Huss et al., 2013). These
exposures were again assigned to occupational codes using dedicated
JEMs, and adjusted for in the main model.
We tested models for the proportionality assumption using statis-
tical tests based on Schoenfeld residuals, and the assumption was met
for all exposure variables.
2.3. Meta-analysis
We performed a meta-analysis on the association between occupa-
tional exposure to ELF-MF and risk of AML. We searched EMBASE and
MEDLINE and additionally screened a specialist data base (www.EMF-
Portal.com). Search terms and a flow chart are provided in the
Supplementary Materials eFig. 1. We included peer-reviewed papers
published in English language until September 2017 if they reported
risk estimates of AML in association with occupational exposure to ELF-
MF or occupational titles grouped as “electrical workers”. Data were
extracted from the individual studies by A.H., and in case of doubt,
discussed and questions resolved with R.V. If risk estimates were pre-
sented for more than two ELF-MF exposure levels (e.g. high vs low and
medium vs low), we pooled risk estimates across all presented exposure
categories (except the reference group), using a fixed effects within-
study meta-analysis. In this way we obtained a risk estimate for “any”
ELF-MF exposure. In addition, we extracted risk estimates if authors
had reported higher ELF-MF exposure category (“highest vs lowest”).
We preferred adjusted risk estimates over unadjusted ones.
We calculated summary risk estimates with a random effects meta-
analysis, and an I2 value, which gives an indication of heterogeneity
between the studies. We used meta-regression to evaluate if study re-
sults differed depending on whether exposure had been assessed as ELF-
MF exposure (e.g. assigned with a job exposure matrix) or was based on
job titles grouped as “electrical occupations”. We also evaluated if study
results differed depending on whether the cumulative exposure of the
full occupational history (i.e. all occupations a person had) was used to
assign ELF-MF exposure, or just some points in time (e.g. at a census).
Finally, we checked if results differed depending on if the original
studies had evaluated incident AML cases, or mortality.
All analyses were performed using Stata version 12 (StataCorp,
College Station, Texas, USA). Results are reported as hazard ratios
(HRs) with 95% confidence intervals (95%CI).
3. Results
The census 1990 contained information on 3.055 million persons
aged between 30 and 62 years (women) or 30 and 65 years (men). Of
these, we excluded 263,619 due to missing occupational information
and 89,935 who received a pension. This left us with 2.701 million
persons for the analysis restricted to 1990–2000, of which 559,803
reported to be homemakers, or seeking a job. The 2000 census had
information on 3.471 million persons aged between 30 and 62 (women)
or 30–65 (men). We excluded 854,706 persons with missing occupa-
tional information and 100,963 pensioners, which left us with 2.515
million person for the analysis restricted to 2000–2008, of which
498,524 reported to be homemakers. A total of 3.147 million persons
contributed to the main analysis from 1990 to 2008, and 1.010 million
persons contributed to the duration analysis of both censuses combined.
Characteristics of our study population are given in Table 2.
No clear exposure-response relationships emerged with increasing
intensity or duration of exposure in the main analysis combining the
two censuses (Table 3), the separate census analyses (Supplementary
material eTable 2) or when we combined the exposures across the
censuses for those people who could be assigned an exposure level for
both censuses (Supplementary material eTable 3). HRs were slightly
elevated for myeloid leukaemias with an HR for ever-high exposed men
of 1.31 (95% CI 1.02–1.67) in the combined census analysis, primarily
due to a slightly elevated risk of AML with an HR of 1.26 (95%CI
0.93–1.70) (Table 4). The increase in risks were restricted to men, HR
for women could not be assessed for most outcomes, as there were too
few “ever high” exposed women for most of the outcomes (Table 4).
1990 2000
Exposure level Low Medium High Low Medium High
Average age at entry Mean (SD) 45 (9) 45 (9) 45 (10) 45 (9) 45 (9) 44 (9)
% women 54 34 8 52 36 7
% educ. level low 23 30 27 14 22 17
medium 53 57 60 55 63 67
high 24 13 13 31 15 16
% foreign nationals 16 29 30 19 29 27
Language region % German 73 74 71 73 75 71
French 23 22 24 23 21 24
Italian 4 4 5 4 4 5
Civil status Single 9 11 10 17 17 18
Married 76 74 79 73 71 73
Widowed 5 4 3 1 2 1
Divorced 10 11 8 9 10 8
Exposure levels: the median intensity of the exposures corresponded to approximately 0.11, 0.19 and 0.52 µT for low, medium and high exposure. Educational level was classified as low
(compulsory schooling or less), medium (vocational training) or high (tertiary education).
Table 2
Exposure levels and characteristics of the study population.
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There were only few outcomes with enough exposed cases to evaluate if
workers had been high exposed at the census 1990 and 2000 and ad-
ditionally at vocational training (Supplementary material eTable 4).
The HR for myeloid leukaemia in men who had been both high exposed
in 1990 and in 2000 was 1.51 (95%CI 0.66–3.46), compared to being
only low exposed in both censuses. For AML, the corresponding HR was
1.85 (95%CI 0.80–4.24). If workers had additionally been high exposed
during vocational training, the HRs increased to 2.24 (95%CI
0.91–5.53) and 2.75 (95%CI 1.11–6.83) for myeloid leukaemias and
AML in men, respectively. These risk estimates were based on 6 high
exposed cases of myeloid leukaemia during both censuses and the same
amount of AML cases; and on 5 cases each if workers had additionally
been high exposed during vocational training. Adjusting the HR for
myeloid leukaemia and AML for potential other occupational exposures
(pesticides, solvents or risk of shocks) did not materially affect HRs.
HRs slightly increased when we adjusted for metal exposure HR for
myeloid leukaemia in ever-high ELF-MF exposed men was 1.38 (95%CI
1.06–1.79). HRs were slightly attenuated when we set all homemakers
to low exposure; HRs for ever-high exposed persons were 1.25 (95%CI
0.98–1.59) and 1.22 (95%CI 0.91–1.63) for myeloid leukaemia and
AML, respectively. Finally, elevated risks were also observed for lung
cancer mortality, ever medium/ high ELF-MF exposed workers had an
HR of 1.25 (95%CI 1.14–1.38), and in always medium/ high exposed
workers this HR was also 1.25 (95%CI 1.15–1.36), see also Table 3.
The forest plot of the meta-analysis on occupational ELF-MF ex-
posure and AML risk is shown in Fig. 1. Including our study results, the
overall summary relative risk (sRR) was 1.21 (95%CI 1.08–1.37). In
some studies, cumulative ELF-MF exposure had been evaluated over the
full occupational history. In this group, the sRR was 1.51 (95%CI
1.06–1.37); studies that had evaluated ELF-MF exposure at just one or
two points in time did not identify increased risks of AML, the sRR was
0.97 (95%CI 0.83–1.13), this difference was statistically significant
(p= 0.03). Studies on electrical occupations resulted in a sRR of 1.32
(95%CI 1.14–1.53). Summary RR were not statistically significantly
different if authors had assessed incidence or mortality (p=0.7).
Exposure level N HR 1990–2008 HR 1990–2008
Sex-adjusted Fully adjusted
Any hematolymphopoietic cancer Low 5223 Referent Referent
Medium 1738 1.07 (1.01–1.13) 1.04 (0.99–1.10)
High 287 1.12 (1.00–1.27) 1.09 (0.97–1.23)
leukaemias (except lymphoid) Low 1301 Referent Referent
Medium 402 1.00 (0.89–1.12) 0.98 (0.87–1.10)
High 78 1.26 (1.00–1.58) 1.22 (0.97–1.54)
leukaemias (incl. lymphoid) Low 1910 Referent Referent
Medium 617 1.04 (0.95–1.14) 1.02 (0.93–1.12)
High 113 1.20 (0.99–1.46) 1.17 (0.97–1.42)
Myeloid leukaemias Low 1161 Referent Referent
Medium 360 1.00 (0.89–1.13) 0.98 (0.87–1.10)
High 72 1.31 (1.03–1.66) 1.26 (0.99–1.60)
AML Low 814 Referent Referent
Medium 248 0.99 (0.86–1.14) 0.97 (0.84–1.13)
High 48 1.27 (0.95–1.70) 1.24 (0.92–1.66)
CML Low 256 Referent Referent
Medium 83 1.04 (0.81–1.34) 1.01 (0.78–1.30)
High 15 1.20 (0.71–2.02) 1.14 (0.67–1.93)
Non-Hodgkin Lymphomas Low 2598 Referent Referent
Medium 888 1.09 (1.01–1.18) 1.07 (0.99–1.15)
High 142 1.10 (0.93–1.30) 1.06 (0.89–1.26)
Lymphoid leukaemias Low 613 Referent Referent
Medium 215 1.11 (0.95–1.30) 1.09 (0.93–1.27)
High 35 1.09 (0.77–1.53) 1.06 (0.75–1.50)
ALL Low 109 Referent Referent
Exposeda 39 1.04 (0.72–1.50) 1.07 (0.73–1.55)
CLL Low 458 Referent Referent
Medium 157 1.07 (0.89–1.29) 1.04 (0.87–1.25)
High 27 1.08 (0.73–1.60) 1.04 (0.71–1.55)
Follicular Lymphoma Low 65 Referent Referent
Exposeda 14a 0.62 (0.35–1.11) 0.60 (0.33–1.08)
Diffuse large B-cell lymphoma Low 95 Referent Referent
Exposeda 34 1.02 (0.69–1.51) 1.00 (0.67–1.50)
Waldenström's macroglub. Low 93 Referent Referent
Medium 16 0.54 (0.32–0.91) 0.49 (0.29–0.85)
High 8 1.58 (0.76–3.26) 1.42 (0.68–2.94)
Multiple myeloma Low 1142 Referent Referent
Medium 375 1.05 (0.93–1.18) 1.04 (0.92–1.17)
High 54 0.99 (0.75–1.30) 0.96 (0.73–1.27)
Hodgkin lymphoma Low 200 Referent Referent
Medium 61 1.00 (0.75–1.34) 0.99 (0.74–1.33)
High 12 1.27 (0.71–2.29) 1.25 (0.69–2.26)
Lung cancer Low 14854 Referent Referent
Medium 5801 1.21 (1.18–1.25) 1.11 (1.07–1.14)
High 1079 1.35 (1.27–1.43) 1.21 (1.14–1.29)
Sex-adjusted HR calculated taking age as underlying time scale and adjusted for sex. Fully adjusted models additionally adjusted for nationality, educational level, language region and
civil status.
a exposed: If there were less than 5 cases in the high exposed group, medium and high exposed were collapsed to an “exposed” category.
Table 3
Risk estimates for ever-exposure to ELF-MF and mortality from hematolymphopoietic cancers, follow-up time 1990–2008.
Published in finale edited form as: Environ Res. 2018 Jul;164:467-474. doi: 10.1016/j.envres.2018.03.022
4. Discussion
We assigned levels of exposure to ELF-MF to occupations reported in
the census 1990 and 2000 in the Swiss population and evaluated risks
of a range of different types of hematolymphopoietic malignancies by
ELF-MF exposure. We observed increased risks of few malignancies in
ever-high exposed workers, but associations generally failed to reach
conventional levels of statistical significance. Also no statistically sig-
nificant increased risks emerged when we analysed information from
two censuses, indicating longer duration of exposure. For myeloid
leukaemia and AML, we observed an increased risk in men ever-high
exposed at both censuses. This HR further increased in men who had
additionally been high exposed during vocational training, but HRs
were based on few exposed cases. Our findings are in line with meta-
analysed results on previous studies evaluating occupational exposure
to ELF-MF and risk of AML. Overall, results indicate that studies eval-
uating cumulative exposure were more likely to observe increased risks.
Risks could not be assessed in women due to low numbers of exposed
persons.
Strengths of our analysis include that we could study the entire
Swiss population aged 30 years or older, with almost 20 years of follow-
up during which a large number of deaths from hematolymphopoietic
malignancies occurred. Occupational information (i.e. job title) was
collected at two censuses ten years apart. Note that the ELF-MF JEM
does not have a time axis, and that it is unclear if exposure levels may
have changed during the time frame of the study (1990–2008).
We were unable to account for effects of actual cumulative exposure to
ELF-MF during one's lifetime, or to assess the effect of timing of ex-
posure on the outcomes. However, when we assigned exposure to vo-
cational training as well as to both censuses, increased risk for AML
emerged in high-exposed workers, and our results are in line those from
studies that identified high exposed workers and evaluated the full
occupational history of study participants (eFig. 2).
Many previous publications have reported associations of ELF-MF
on a combined but heterogeneous group of hematolymphopoietic ma-
lignancies. In this case, it is not possible to assess if associations with
the exposure are restricted to subgroups of leukaemia or lymphoma. In
a previous meta-analysis, associations of magnetic field exposure were
stronger with subtypes like CLL or ALL than with hematolymphopoietic
cancers overall. Since this meta-analysis, several new studies have been
published that addressed occupational ELF-MF exposure and risk of
AML (Sorahan, 2014; Koeman et al., 2014; Talibov et al., 2015). Be-
cause our results indicated that possibly high ELF-MF exposure in
combination with duration of exposure may represent a risk factor for
Table 4
Risk estimates for ever-exposure to ELF-MF and mortality from hematolymphopoietic cancers, follow-up time 1990–2008, stratified by sex.
Exposure level N HR fully adj., men N HR fully adj., women
Any hematolymphopoietic cancer Low 3817 Referent 1406 Referent
Medium 1322 1.04 (0.97–1.11) 416 1.05 (0.94–1.18)
High 274 1.10 (0.97–1.24) 13 0.95 (0.55–1.65)
leukaemias (except lymphoid) Low 919 Referent 382 Referent
Medium 305 0.99 (0.87–1.13) 99a 0.92 (0.73–1.17)
High 76 1.26 (1.00–1.60) – –
leukaemias (incl. lymphoid) Low 1395 Referent 515 Referent
Medium 487 1.05 (0.94–1.16) 134a 0.92 (0.76–1.13)
High 109 1.19 (0.98–1.45) – –
Myeloid leukaemias Low 815 Referent 352 Referent
Medium 271 0.99 (0.86–1.14) 92a 0.93 (0.73–1.18)
High 70 1.31 (1.02–1.67) – –
AML Low 562 Referent 252 Referent
Medium 180 0.96 (0.81–1.14) 70a 1.03 (0.78–1.35)
High 46 1.26 (0.93–1.70) – –
CML Low 184 Referent 72 Referent
Medium 65 1.06 (0.79–1.41) 18a 0.78 (0.45–1.34)
High 15 1.23 (0.73–2.10) – –
Non-Hodgkin Lymphomas Low 1951 Referent 647 Referent
Medium 682 1.05 (0.96–1.14) 209a 1.11 (0.95–1.31)
High 139 1.08 (0.91–1.29) – –
Lymphoid leukaemias Low 480 Referent 133 Referent
Medium 182 1.14 (0.96–1.35) 35a 0.93 (0.63–1.37)
High 33 1.05 (0.73–1.49) – –
ALL Low 67 Referent 42 Referent
Exposed 30a 1.21 (0.78–1.89) 9a 0.83 (0.39–1.75)
CLL Low 377 Referent 81 Referent
Medium 135 1.06 (0.87–1.29) 23a 1.00 (0.61–1.62)
High 26 1.03 (0.69–1.54) – –
Follicular Lymphoma Low 41 Referent 24 Referent
Exposeda 10a 0.62 (0.31–1.25) < 5a –
Diffuse large B-cell lymphoma Low 59 Referent 36 Referent
Exposeda 26a 1.10 (0.69–1.76) 8a 0.76 (0.35–1.69)
Waldenström's macroglub. Low 75 Referent 18 Referent
Medium 15 0.56 (0.32–0.98) < 5a –
High 7 1.30 (0.60–2.84) – –
Multiple myeloma Low 808 Referent 334 Referent
Medium 279 1.04 (0.91–1.20) 96 0.98 (0.77–1.24)
High 48 0.91 (0.68–1.22) 6 1.70 (0.75–3.84)
Hodgkin lymphoma Low 141 Referent 58 Referent
Medium 49 1.02 (0.73–1.42) 16a 0.97 (0.54–1.74)
High 12 1.25 (0.69–2.27) – –
Exposure as ever only low, ever medium or ever high as reported in census 1990 or census 2000. Model 1: Adjusted for nationality, educational level, language region and civil status,
taking age as underlying time scale, in men. Model 2: Same as Model 1, but in women.
a For less than 5 high exposed cases, risk estimates of medium and high exposed were combined. In the case of fewer than 5 medium or high exposed cases, corresponding risk estimates
were omitted.
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AML, we performed a systematic search of studies and meta-analysed
studies that had reported results for AML. As shown in Fig. 1, the
combined sRR was 1.21 (95%CI 1.08–1.37), and our results of ever-
high exposed workers was well in line with this estimate.
One previous study reported that residential ELF-MF exposure was
associated with a subtype of AML (AML with multi-lineage dysplasia)
but not with total AML (Wong et al., 2009). Incidence of AML subtypes
has been shown to vary substantially by sex, age and race or ethnicity
group (Dores et al., 2012). Given that these subtypes of AML were
generally not reported, we could not evaluate whether a differential
distribution of subtypes across the meta-analysed studies could be un-
derlying the observed heterogeneity. Nevertheless, given that the thus
far evaluated hematolymphopoietic cancers represent a diverse group
of diseases, our findings underline that future investigation into the
separate entities are more likely to be more informative compared to
grouping them together.
Some publications also summarised all non-Hodgkin lymphomas as
a group (Karipidis et al., 2007; Schroeder and Savitz, 1997; Linet et al.,
1993; Mester et al., 2006; Miller et al., 1996; t Mannetje et al., 2016;
Villeneuve et al., 2000; Zheng et al., 2002). Subtypes of non-Hodgkin
lymphoma such as follicular lymphoma or diffuse large B-cell lym-
phoma or other lymphomas, such as multiple myeloma, or Hodgkin
lymphoma, were less frequently analysed (Floderus et al., 1999;
Schroeder and Savitz, 1997; t Mannetje et al., 2016; Zheng et al., 2002;
Coggon et al., 1986; Fear et al., 1996; Milham, 1985). Two previous
studies reported statistically significant increased risk of follicular
lymphoma in workers occupationally exposed to magnetic fields
(Koeman et al., 2014; Mester et al., 2006). Another study observed
increased risks of follicular lymphoma in workers of electric power
systems industries (Band et al., 2004) and hypothesised a possible as-
sociation with magnetic field exposure. Follicular lymphoma was also
increased in male and in female workers in the telephone commu-
nication industry (Zheng et al., 2002), but another study provided no
evidence of an increased risk of follicular lymphoma in electrical or
Fig. 1. Meta-analysis of occupational exposure to ELF-MF and risk of acute myeloid leukaemia. Overview over studies analysing electrical occupations, or (any) occupational ELF-MF
exposure compared to background, and risk of acute myelogenous leukaemia. Most studies evaluated job codes as “electrical occupations” or assigned magnetic field exposures to job
codes using a job exposure matrix. Often this was based on few points in time, e.g. at baseline, census, or a primary held job. Four studies evaluated the full occupational history and
assigned cumulative magnetic field exposure to all occupations study participants had held.
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hematolymphopoietic malignancies, although it has been hypothesised
that exposure to ELF-MF generates reactive oxygen species (ROS),
which in turn may eventually trigger genotoxic events (Consales et al.,
2012).
Overall, our analysis is in line with previous reports stating that if
there is any risk of occupational magnetic field exposure on hemato-
lymphopoietic cancers, it appears to be restricted to some subtypes of
these cancers, and it appears to be small.
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